创模生物科技(北京)有限公司

CN / En

NEWS

Features of the InnoModels Biotechnology Immunoculture Kill Model

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-22 14:38
  • Views:

(Summary description)In today's field of medical research, the immune co-culture kill model represents an innovative exploration of the field in which InnoModels Biotechnology is playing an important role. The introduction of this technology provides a unique way to understand how the immune system responds to disease, infection, and other physiological and pathological processes

Features of the InnoModels Biotechnology Immunoculture Kill Model

(Summary description)In today's field of medical research, the immune co-culture kill model represents an innovative exploration of the field in which InnoModels Biotechnology is playing an important role. The introduction of this technology provides a unique way to understand how the immune system responds to disease, infection, and other physiological and pathological processes

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-22 14:38
  • Views:
Information

In today's field of medical research, the immune co-culture kill model represents an innovative exploration of the field in which InnoModels Biotechnology is playing an important role. The introduction of this technology provides a unique way to understand how the immune system responds to disease, infection, and other physiological and pathological processes. The following are some of the key aspects involved in exploring immune co-culture killing models:
1. Simulating real-world situations
The immune co-culture killing model simulates the interactions between immune cells in the immune system through an in vitro experimental system, thus providing an experimental environment that is close to a real situation. This model allows researchers to better understand the role and interrelationships of immune cells in infections, tumors and autoimmune diseases.
2. Controlled experimental conditions
The InnoModels Biotechnology Co-Culture Killing Model allows researchers to control experimental conditions, including cell type, concentration, incubation time, and other parameters. This flexibility allows researchers to design and perform various types of experiments to address specific immunological questions.
3. Simulating immune cell interactions
The model is able to simulate the interactions between different types of immune cells, such as T cells, B cells, macrophages, etc. By simulating the interactions between these cells, researchers can gain a deeper understanding of the mechanisms of immune cells in recognizing and removing pathogens, tumor cells, and so on.

 


4. Visualization and real-time monitoring
Immune co-culture killing models allow researchers to monitor the process of cellular interactions in real time through techniques such as microscopy. This real-time monitoring can provide important information about the dynamics of cellular interactions, providing researchers with deeper insights.
5. Applications in drug discovery and immunotherapy
The InnoModels Bio-Immune Co-Culture Killing Model has great potential for drug discovery and immunotherapy. Through the model, researchers can assess the immunoreactivity, toxicity, and effects on immune cell interactions of novel drugs, providing important reference data for drug development.
Conclusion
The emergence of immune co-culture killing model provides a brand new direction and idea for immunological research. The continuous innovation and exploration in this field by InnoModels Bio will further promote the development of immunological research and provide important support for the research and development of novel drugs and clinical treatment.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司